Skip to main content

Table 1 Characteristics at baseline before PSM: sample of dizziness or vertigo

From: Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China

Variable

Total (N = 2057)

Gastrodin injection (N = 1529)

Extract of Ginkgo Biloba Leaves injection (N = 528)

P

Region, (n, %)

   

 < 0.001

 Eastern

1079 (52.5)

824 (53.9)

255 (48.3)

 

 Central

363 (17.6)

206 (13.5)

157 (29.7)

 

 Western

556 (27.0)

449 (29.4)

107 (20.3)

 

 Northeast

59 (2.9)

50 (3.3)

9 (1.7)

 

Hospital level, (n, %)

   

 < 0.001

 Tertiary

1889 (91.8)

1384 (90.5)

505 (95.6)

 

 Secondary

139 (6.8)

122 (8.0)

17 (3.2)

 

 Primary

29 (1.4)

23 (1.5)

6 (1.1)

 

Hospital department, (n, %)

   

 < 0.001

 Neurology

1492 (72.5)

1179 (77.1)

313 (59.3)

 

 E.N.T

146 (7.1)

37 (2.4)

109 (20.6)

 

 Cardiovascular medicine

29 (1.4)

23 (1.5)

6 (1.1)

 

 ICU

390 (19.0)

0

0

 

 Others

55 (45, 64)

290 (19.0)

100 (18.9)

 

Age (y), (n, %)

   

0.674

 [18, 45]

514 (25.0)

377 (24.7)

137 (25.9)

 

 [45,60]

750 (36.5)

555 (36.3)

195 (36.9)

 

 [60,75]

758 (36.8)

568 (37.1)

190 (36.0)

 

 ≥ 75

35 (1.7)

29 (1.9)

6 (1.1)

 

Gender (n, %)

   

0.959

 Female

1235 (60.0)

917 (60.0)

318 (60.2)

 

 Male

822 (40.0)

612 (40.0)

210 (39.8)

Â